Nov 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Therapeutics, Brown-Forman and Ulta Beauty on Friday.
HIGHLIGHTS
* Applied Therapeutics Inc : RBC cuts to sector perform from outperform
* Brown-Forman : Barclays cuts target price to $49 from $53
* Descartes Systems Group Inc : RBC raises target price to $133 from $115
* The J.M. Smucker Company : Barclays raises target price to $126 from $121
* Ulta Beauty Inc : Citigroup raises target price to $390 from $345
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Applied Therapeutics Inc : RBC cuts to sector perform from outperform
* Applied Therapeutics Inc : RBC cuts target price to $4 from $12
* Brown-Forman : Barclays cuts target price to $49 from $53
* CF Industries Holdings Inc : Berenberg raises target price to $74 from $69
* Descartes Systems Group Inc : RBC raises target price to $133 from $115
* Domo Inc : TD Cowen raises target price to $10 from $9
* Pfizer : Berenberg raises target price to $29 from $27
* Smurfit Westrock Plc : JP Morgan raises target price to $69 from $65
* Splash Beverage Group Inc : H.C. Wainwright cuts target price to $0.5 from $1
* The J.M. Smucker Company : Barclays raises target price to $126 from $121
* TXNM Energy : Barclays raises target price to $52 from $46
* Ulta Beauty Inc : Citigroup raises target price to $390 from $345
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))